A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Senior Director - Strategic Accounts

Account ManagementConfirmed live in the last 24 hours
Full-timeRemote in USA$238k - $322kRemote

About the Job

Requirements

  • A bachelor's degree in a Science or Business discipline is required.
  • At least 10 years of commercial leadership experience within the biopharmaceutical or life sciences industry is required.
  • At least 5 years of strategic account management experience working with integrated delivery networks (IDNs) and health systems is required.
  • At least 5 years of people leadership experience, including coaching, developing, and leading high-performing teams, is required.
  • Demonstrated success leading complex, cross-functional initiatives within a matrixed organization is required.
  • A strong understanding of the healthcare environment, including provider systems, payer dynamics, reimbursement, contracting, formulary management, and value-based care models, is required.
  • Executive presence and the ability to influence and engage senior customer and internal stakeholders, including C-suite leaders, are required.
  • High proficiency in Microsoft Office applications, including Excel, PowerPoint, and Word, is required.

Responsibilities

  • Guide development and execution of account strategies, objectives, and key performance indicators aligned to organizational and brand priorities.
  • Anticipate industry, market, and customer trends to inform long-term account strategy and organizational direction.
  • Partner with cross-functional leaders to deliver an integrated customer experience and maximize organizational impact.
  • Consult with partners on industry trends and best practices to address complex and emerging challenges and opportunities by engaging with senior stakeholders.
  • Lead, coach, and develop a high-performing team of Health System Directors to achieve business objectives and customer impact.
  • Foster a culture of accountability, collaboration, innovation, compliance, and continuous development.
  • Guide Health System Directors in building and sustaining executive-level customer relationships that improve strategic partnerships and mutually beneficial priorities.
  • Monitor account performance and business results, providing feedback, best practices, and direction to optimize and ensure consistent execution.
  • Partner with the Vice President, Strategic Accounts to advance the Strategic Account Management strategy, capabilities, and organizational effectiveness.
  • Lead change initiatives and capability-building efforts that strengthen competitive advantage and customer engagement.
  • Establish and monitor key performance indicators to measure account, team, and program impact.
  • Support executive-to-executive customer engagements and strategic partnership initiatives.
  • Communicate the value and outcomes of Strategic Accounts through performance reporting, customer success stories, and business reviews.

Desired Qualifications

  • An advanced degree (MBA, MS, PhD, or healthcare certification) is desired.
  • Additional experience working with infusion providers or similar organized customers would be beneficial.
  • A master's degree, specifically an MBA, is preferred.
  • Experience in rare disease markets is preferred.
  • Active participation in relevant pharmaceutical, healthcare, or account management professional associations is preferred.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs